Quarterly report [Sections 13 or 15(d)]

Unaudited Interim Condensed Consolidated Statements of Cash Flows

v3.25.1
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows From Operating Activities:    
Net loss $ (3,493) $ (4,234)
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities:    
Depreciation and amortization 1,697 1,594
Stock-based compensation 4,217 4,318
Change in fair value of warrant liabilities (2,752) (3,478)
Gain on lease modification 0 (47)
Accretion of interest income on held-to-maturity securities (723) (1,481)
Deferred tax benefit (17) (84)
Bad debt expense 30 31
Other 63 3
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 2,254 (416)
Accounts receivable (520) (2,609)
Other non-current assets 13 (44)
Operating right-of-use assets/lease liabilities (30) (27)
Accounts payable and accrued expenses (2,278) (10,237)
Deferred revenue 1,293 1,160
Net cash used in operating activities (246) (15,551)
Cash Flows From Investing Activities:    
Capitalized software development costs (532) (311)
Purchase of property and equipment (2,619) (816)
Proceeds from disposal of property and equipment 5 0
Purchase of held-to-maturity investments (84,197) (77,051)
Proceeds from maturities of held-to-maturity investments 107,750 102,740
Net cash provided by investing activities 20,407 24,562
Cash Flows From Financing Activities:    
Proceeds from the exercise of common stock options 60 91
Taxes paid related to net share settlement of equity awards (4,306) (37)
Net cash (used in) / provided by financing activities (4,246) 54
Effect of foreign exchange rate changes on cash balances 126 (26)
Net increase in cash and cash equivalents and restricted cash 16,041 9,039
Cash and cash equivalents and restricted cash - beginning 19,647 29,021
Cash and cash equivalents and restricted cash - ending 35,688 38,060
Reconciliation to unaudited interim condensed consolidated balance sheets    
Cash and cash equivalents 34,830 36,758
Restricted cash 858 1,302
Total cash and cash equivalents and restricted cash 35,688 38,060
Non-cash investing and financing activities:    
New leases under ASC 842 entered into during the period 608 2,581
Common stock issued for settlement of earn-out previously in accounts payable and accrued expenses 0 3,022
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses $ 339 $ 285